Villalobos Bollen, M. A., Czapiewski, P., Reinmuth, N., Fischer, J., Andreas, S., Kortsik, C., . . . Thomas, M. (2019). Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab. Oncology letters, 17(6), . https://doi.org/10.3892/ol.2019.10153
Chicago-Zitierstil (17. Ausg.)Villalobos Bollen, Matthias Americo, et al. "Impact of EMT in Stage IIIB/IV NSCLC Treated with Erlotinib and Bevacizumab When Compared with Cisplatin, Gemcitabine and Bevacizumab." Oncology Letters 17, no. 6 (2019). https://doi.org/10.3892/ol.2019.10153.
MLA-Zitierstil (9. Ausg.)Villalobos Bollen, Matthias Americo, et al. "Impact of EMT in Stage IIIB/IV NSCLC Treated with Erlotinib and Bevacizumab When Compared with Cisplatin, Gemcitabine and Bevacizumab." Oncology Letters, vol. 17, no. 6, 2019, https://doi.org/10.3892/ol.2019.10153.